Darzalex Daratumumab 500 mg Injection
Darzalex Daratumumab 500 mg Injection is an advanced immunotherapy used in the treatment of Multiple Myeloma, a serious form of blood cancer that affects plasma cells in the bone marrow.
It contains daratumumab, a monoclonal antibody that specifically targets the CD38 antigen on malignant plasma cells. This action helps the immune system identify and destroy cancer cells, reducing disease progression and improving survival outcomes. The 500 mg formulation is widely used in combination therapy protocols in oncology.
📞 Contact Details to Place Order
💬 WhatsApp: +91 9730316395
📞 Phone: +91 9730316395
📧 Email: info@globmedindia.com
Composition & Content
- Active Ingredient: Daratumumab – 500 mg
- Drug Class: CD38-directed monoclonal antibody
- Form: Sterile injectable solution (IV or subcutaneous depending on protocol)
- Excipients: Stabilizers, buffering agents, and sterile water for injection
How to Use
- Administered only by qualified healthcare professionals
- Given via intravenous infusion or subcutaneous injection depending on treatment plan
- Pre-medications (antihistamines, corticosteroids, antipyretics) are recommended
- Patients must be monitored during and after administration for reactions
Dosage
Dosage is determined by an oncologist based on patient condition:
- Initial phase: Weekly dosing schedule
- Follow-up phase: Every 2 weeks
- Maintenance phase: Monthly administration
- Often combined with other anti-myeloma therapies
Uses & Treatments
Darzalex 500 mg Injection is used for:
- Newly diagnosed multiple myeloma
- Relapsed or refractory multiple myeloma
- Combination therapy with chemotherapy or immunotherapy
- Maintenance therapy under oncology supervision
Advantages
- Targets CD38-positive cancer cells precisely
- Improves progression-free and overall survival
- Can be combined with standard treatment regimens
- Reduces tumor burden effectively
- Well-established in hematologic oncology practice
Storage Conditions
- Store at 2°C to 8°C (refrigerated conditions)
- Do not freeze
- Keep in original packaging to protect from light
- Do not shake the vial
- Keep out of reach of children
Alternative Indian Brands / Options
Currently, Daratumumab is primarily available as the innovator brand Darzalex. In India and other markets, alternatives may include:
- Daratumumab biosimilars (availability depends on regulatory approvals)
- Other multiple myeloma therapies:
- Bortezomib
- Lenalidomide
- Carfilzomib
All treatment decisions must be made under oncologist supervision.
Buy Darzalex Daratumumab 500 mg Injection in South Africa – GlobMedIndia
Looking to buy Darzalex Daratumumab 500 mg Injection in South Africa and surrounding regions? GlobMedIndia – The Medicine Exporter provides fast, safe, and secure access to anti-cancer medicines across Africa with reliable international delivery support.
We serve major regions including:
- Johannesburg
- Cape Town
- Pretoria
- Polokwane
- Germiston
- Nelspruit
- Botswana
- Lesotho
- Mozambique
- Namibia
- Swaziland
- Zimbabwe
🌟 Why Choose GlobMedIndia?
- Trusted global exporter of oncology medicines
- Secure temperature-controlled shipping
- Fast international delivery network
- Quality-assured pharmaceutical sourcing
- Dedicated support for prescription-based orders
